Category Archives: IPR policy

RCEP and affordable medicines: Civil society reaches out to Minister of Commerce Suresh Prabhu

12th Nov 2018, New Delhi The RCEP ministerial meeting is taking place today, 12th November, 2018 in Singapore. It will be followed by Leaders’ Summit on 14th November. There are clear indications that countries want to wrap up the negotiations that started in … Continue reading

Posted in Fix the patent law, IPR policy, Regional Comprehensive Economic Partnership | Leave a comment

Intellectual Property rules stand amended

Source: The Hindu | July 02, 2018 Some powers with Customs revoked The Union Ministry of Finance has amended Intellectual Property rules to revoke the power vested with Customs authorities to seize imported products based on complaints of patent infringement. … Continue reading

Posted in IPR Enforcement, IPR policy, Patent infringement | Leave a comment

South African Cabinet approves new Intellectual Property Policy

Source: Fix the Patent Laws | May 24, 2018 The Fix the Patent Laws Coalition (FTPL) welcomes the news today that the Cabinet of the Government of South Africa has approved the new Intellectual Property (IP) Policy. After nine years of … Continue reading

Posted in Africa, Fix the patent law, IPR policy, Patent, Uncategorized | Leave a comment

China calls for common front on US S.301 measures Published in SUNS #8673 dated 2 May 2018

Source: Third World Network | May 03, 2018 Geneva, 30 Apr (D. Ravi Kanth) – China has called for a common front against the United States at the World Trade Organization for fighting the “unilateralism and protectionism” unleashed by Washington … Continue reading

Posted in IPR policy, WTO | Leave a comment

A ‘New’ Recipe for Trade

By Shalini Bhutani, The Economic & Political Weekly (Vol. 52 Issue No. 7) With other mega regional trade agreements like the Trans–Pacific Partnership in uncertainty, trade treaties like the Regional Comprehensive Economic Partnership will acquire greater significance beyond their original … Continue reading

Posted in IPR policy, Regional Comprehensive Economic Partnership, TPP, Transatlantic Trade and Investment Partnership (TTIP), TRIPS plus, Uncategorized | Leave a comment

Indian pharma at odds with US trade group over USTR Priority Watch List

The tug of war continues. Even as the Indian Pharmaceutical Alliance, the domestic drug industry lobby group, has appealed to the US Trade Representative to remove India from its Priority Watch List – the latter includes countries that are alleged … Continue reading

Posted in IP Rights, IPR, IPR policy, Special 301 report, Uncategorized, USTR 301 report | Leave a comment

Our view on India and US Joint Statement on the Trade Policy Forum Delhi – October 20, 2016

In the recently concluded US India Trade Policy Forum meeting held in Delhi, both countries laid emphasis on the importance of having a robust and balanced IPR protection in fostering creativity, promoting innovation, and attracting investment. Indian government was praised … Continue reading

Posted in IPR, IPR policy, TRIPS plus, Uncategorized | Leave a comment